Neal Walker Aclaris Therapeutics, Inc. (ACRS) insider trading activity
Neal Walker is INTERIM PRESIDENT AND CEO of Aclaris Therapeutics, Inc.. Currently has a direct ownership of 1.29 Million shares of ACRS, which is worth approximately $1.33 Million. The most recent transaction as insider was on May 01, 2024, when has been sold 2,784 shares (Common Stock) at a price of $1.26 per share, resulting in proceeds of $3,507. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.29M
1.01%
3M change
1.51%
12M change
Total Value Held
$1.33 Million
Neal Walker Transaction History
Also insider at
NW
Neal Walker
INTERIM PRESIDENT AND CEO
Wayne, PA